Accell attended Immuno-Oncology 360° held in NYC in February 2020

On February 26-28, 2020 Natalia Nayanova, Accell’s Managing Member, headed to New York City, NY to attend the annual conference “Immuno-Oncology 360°” held in Crowne Plaza Times Square. Organized by The Conference Forum, Immuno-Oncology 360° convenes...

Partnering at BIO-Europe 2019

BIO-Europe® is held annually in different cities and is an international forum to promote business development between pharmaceutical, financial, and biotechnology companies. In November 2019 Natalia Nayanova, Accell’s founder and Managing Member, attended BIO-Europe...

Accell Presents an Online Oncology Platform – “OncoForum”

Accell Oncology is ready to introduce an innovative approach to organize advisory boards and provide consultancy services with oncology key opinion leaders (KOLs) at the top-level of expertise via unique partner online oncology forum – “OncoForum”.

2019 started with attending 8th Annual Crown Congress in Florida, USA

The year of 2019 began for Accell with the visit of Natalia Nayanova, Accell’s Founder and Director of Clinical Operations, to Orlando, Florida on January 22-24; Natalia attended 8th Annual CROWN Congress. This was an elite gathering of clinical decision-makers aiming...

Accell’s Progress Summary Over 2018

It is the end of 2018, so it is high time to summarize our company’s success over the past year. Natalia Nayanova, Accell’s Founder and Clinical Operations Director, shares her perspective on the company’s overall progress: “I don’t wish to brag, but Accell once again...

Clinical Trials Russia 2018 by Adam Smith Conferences

On November 13-14, 2018 Natalia Nayanova, Accell’s Founder and Director of Clinical Operations, attended an Adam Smith Conference ‘Clinical Trials Russia 2018’ held in Moscow, Russia. This is the only international event that is dedicated to discussing the regulatory,...

ESMO Annual Congress 2018: Accell Oncology Entered Europe

This October Accell has exhibited for the first time at ESMO Annual Congress 2018. The event was held in Munich, Germany from October 18 until October 22, 2018. The European Society for Medical Oncology (ESMO) is the leading European professional organization for...

Accell is a Member of Clinical & Contract Research Association (CCRA)

In September 2018 Accell Clinical Research became an official member of Clinical & Contract Research Association (CCRA) and agreed to abide by the Code of Practice. CCRA is an influential trade organization for UK companies involved in biopharmaceutical research....

Accell is heading East. Meeting summary with Biolake.

On August 7, 2018, Accell’s team had the honor to meet a delegation from The Wuhan National Bio-industry Base and welcome it at our Clinical Operations Headquarters in Saint Petersburg, Russia.

Russia and World Cup 2018: Myths vs. Reality

As most of you know the FIFA World Cup 2018 has just triumphantly ended in Russia. This event brought hundreds of thousands of football fans from all over the world to witness a spectacular month-long tournament all dedicated to soccer. It is high time now to...

EU Clinical Trial Regulation makes Europe more attractive for R&D

Currently, the whole world awaits implementation of Clinical Trial Regulation EU No. 536/2014by the European Medicines Agency (EMA). It comes in collaboration with the Member States and the European Commission. According to the recent update on the EMA website, the...

SCOPE: Summit for Clinical Trial Operations Executives, 2017

The 8th Annual SCOPE Summit took place January 24-26, 2017 in Miami, FL, offering three stimulating days of in-depth discussions in 13 different conferences, 6 pre-conference workshops and 2 symposia focused on issues related to each aspect of clinical trial planning...

Accell Clinical Research will attend ESMO 2016

Accell Clinical Research has been delighted to intensely participate in major global life science events in 2016; this October meet our Business Development team at ESMO 2016 oncology conference held on October 7-11 in Copenhagen, Denmark. The annual ESMO congress is...

Accell attends ‘Women Building Bio: the XX Factor’

September 2016 is an eventful month for Accell Clinical Research business development team: Julia Kondakov, Director of Business Development  and Accell’s Co-founder, will attend the conference ‘Women Building Bio: the XX Factor’ this Thursday, September 29, 2016....

Clinical Operations in Oncology Trials East Coast 2016, Boston

It is a second year in a row that Accell Clinical Research is participating in Clinical Operations in Oncology Trials (CTO) East Coast in the Boston biotech hub. CTO is the only operationally-focused oncology conference in the USA with a dynamic program specifically...

Charlottesville Biotech and Beer

Charlottesville Biotech and Beer Event at UVA is coming up on May 10th! Julia Kondakov will attend this VirginiaBIO networking event – please come find us there. Tuesday, May 10th at 5:50, I.Lab at UVA. To pre-schedule meetings, contact Julia Kondakov at...

Outsourcing in Clinical Trials East Coast 2016

Accell Clinical Research will exhibit at the Outsourcing in Clinical Trials East Coast 2016, May 25-26 2016, King of Prussia, PA. It is an established conference bringing together more than 350 pharmaceutical industry professionals. Julia Kondakov will be there to...

Outsourcing in Clinical Trials (OCT) Israel (16-17 March 2016)

OCT Israel 2016 in Tel Aviv is in less than a month — March 14-15, 2016. We are looking forward to exhibiting for the second consecutive year. Come by our booth to speak with Natalia Nayanova, our Director of Clinical Operations, and Julia Kondakov, Director of...

Clinical Operations in Oncology Trials conference in Amsterdam

Accell Clinical Research Director of Clinical Operations, Dr. Natalia Nayanova’s presentation at the 2015 Clinical Operations in Oncology Trials conference in Amsterdam was a great success. We look forward to seeing you next year. Oncology Treatment Network Structure...

Clinical Trials Conference Russia 2015

The 3rd annual Clinical Trails Conference Russia 2015 is next week, 24th–26th November at the Metropol hotel, Moscow, Russia. Accell Clinical Research’s director of Clinical Operations, Natalia Nayanova, will participate in a panel discussion on Wednesday, Nov. 25th...

Clinical Operations in Oncology Trials Europe 2015

Natalia Nayanova, Director of Clinical Operations, Accell Clinical Research, will be at the Clinical Operations in Oncology Trials (Europe) from December 1st–2nd 2015 in Amsterdam, Netherlands. She will speak on the topic; “Oncology Treatment Network Structure in...

Clinical Trials Innovation Programme (CTIP) 2015

Natalia Nayanova, Director of Clinical Operations, Accell Clinical Research, will speak at the “Clinical Trials Innovation Programme” conference (October 22-23, Frankfurt, Germany). The Clinical Trials Innovation Programme (CTIP) 2015 is an exclusive, invitation-only...

4th Annual Clinical Operations in Oncology Trials

Accell Clinical Research will exhibit at the 4th Annual Clinical Operations in Oncology Trials on July 15–16 in Boston, Massachusetts. Drop by Booth #20 to discuss your clinical trial pipeline with our specialists and to learn about the benefits of oncology research...

2015 BIO International Convention

Accell Clinical Research will participate in 2015 BIO International Convention (June 15-18, 2015, Philadelphia, PA). Visit us at the exhibition to discuss opportunities of conducting clinical trials in Russia & Eastern Europe with our leading specialists! For...

DIA 2015 51st Annual Meeting

Accell Clinical Research will exhibit at the DIA 51st Annual Meeting on June 14-18 in Washington, DC. Drop by Booth #2439 to discuss your clinical trial pipeline with our specialists and to learn about benefits of clinical research in Eastern Europe. We will be happy...

Two new clinical trials in oncology, Russia

One of Accell’s clients, a developer of targeted therapeutics for various tumor types, starts 2 new Phase II clinical trials in Russia. Accell has been performing other clinical studies for this innovative cancer therapy since 2013. The client develops a method of...

OCT Israel 2015

Accell Clinical Research invites biotech and pharmaceutical companies in Israel to Outsourcing in Clinical Trials Israel 2015. OCT Israel will provide a platform for local biotech and pharmaceutical companies to expand their industry network, explore proven strategies...

“Non-small-cell Lung Cancer” Conference

Accell Clinical Research will participate in the international cross-disciplinary conference “Non-small-cell Lung Cancer” (Moscow, February 26-27) organized by RUSSCO (Russian Association of Clinical Oncology). We shall conduct a medical workshop as a part of one of...

Clinical Trial Innovation Programme 2015

Accell Clinical Research will participate in the Clinical Trials Innovation Programme (CTIP) — an exclusive, invitation-only event held annually, helping senior executives from pharma & biotech industries to forge strong and lasting business relationships and to...

Innovative Drug R&D Russia 2014

Accell Clinical Research will participate in the “Innovative Drug R&D Russia 2014” conference (November 18-19, 2014, Moscow). Accell has participated in this event since 2012, this year we are going there to meet our existing and future business partners again....

20th Annual Russian Pharmaceutical Forum

Accell Clinical Research specialists will attend the 20th Annual Russian Pharmaceutical Forum held by Adam Smith Conferences on June 17-19, 2014 in Saint Petersburg, Russia. This event brings together the top players of the Russian pharmaceutical industry. We will be...

DIA 2014 50th Annual Meeting

Accell Clinical Research will exhibit at the DIA 50th Annual Meeting on June 16-18 in San Diego, CA. Drop by Booth #2411 to discuss your clinical trial pipeline with our specialists and to learn about benefits of clinical research in Eastern Europe. We will be happy...

We are Growing & Expanding!

We are delighted to inform our valued clients and partners that we have recently moved our Russian clinical headquarters into a larger office space located just a few steps from our former location. The new office address is Finlyandsky pr., 4-A, Suite 623, Saint...

Patient recruitment expectations exceeded

In an ongoing clinical study in Russian Federation in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D), recruitment expectations were exceeded. Actual enrolment of patients at the time of LPI was 37% above the number of...

Accell is expanding its Russian team

Accell’s team in Saint Petersburg, Russia has increased by four new members since January 2012. We welcome our new Clinical Research Associates to the clinical department. Currently openings remain for new Clinical Research Associates (CRAs) in Russia, Ukraine,...

Accell is starting a new international Phase III clinical study

We started a new international phase III study with patients suffering from acute ulcerative colitis. The study will enroll more than 300 patients in 30 sites in Lithuania, Latvia, Russia and Ukraine. Enrollment in the clinical study will continue until December...

Clinical study at 6 sites in Russia

We have started a clinical study in Russia in 6 sites in patients with a recent coronary acute syndrome (ACS) and type 2 diabetes mellitus (T2D). The study will enroll 60 patients.  

Welcome new business development team member

Accell Clinical Research is pleased to welcome Dr. Zagit Gaymalov as a part of our team. Dr. Gaymalov joins us as a Business Development professional with a strong background in pharmaceutical and research industry. He will lead Business Development efforts in North...

Accell joins a Global CRO Strategic Alliance

Maximax Pharmaceutical Research Inc. launches a global CRO Development Group and expands its strategic alliances with several regional CRO’s to increase the scale, scope and geographic locations of its services to Bio-pharmaceutical companies and research...

Business Development Expands to Netherlands

We are pleased to announce the expansion of our business development activities into the Netherlands. Mila Loginova has become a representative of Accell Clinical Research, LLC in the Netherlands as a Client Relations Manager. Mrs. Loginova is directly responsible for...

14th Russian National Congress “Human and Medicine”

MOSCOW, April 16-20, 2007. ACCELL will participate in the 14th Russian National Congress “Human and Medicine”. We are dedicated to following the cutting-edge trends in the Russian medical community. We would be happy to meet with you during the Congress....